scholarly article | Q13442814 |
P50 | author | Alan Bernard Rickinson | Q21165006 |
Andrew James McMichael | Q21165187 | ||
P2093 | author name string | Chris Hatton | |
Damien Montamat-Sicotte | |||
Margaret F C Callan | |||
Elisabeth Amyes | |||
Nancy Gudgeon | |||
P2860 | cites work | Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 |
Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion | Q28511040 | ||
Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection | Q33784950 | ||
CD27 is required for generation and long-term maintenance of T cell immunity | Q33924191 | ||
A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle | Q35872919 | ||
Massive expansion of antigen-specific CD8+ T cells during an acute virus infection | Q37419599 | ||
Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses | Q39607047 | ||
Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection | Q40309482 | ||
Large clonal expansions of CD8+ T cells in acute infectious mononucleosis | Q40665903 | ||
CD8(+) T-cell selection, function, and death in the primary immune response in vivo | Q40735898 | ||
Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo | Q41764334 | ||
Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection | Q42175278 | ||
Phenotypic and functional separation of memory and effector human CD8+ T cells | Q42951823 | ||
Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection | Q44381226 | ||
A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. | Q44952697 | ||
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections | Q45733084 | ||
Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection | Q45734459 | ||
Stability of virus-specific CD4+ T cell frequencies from acute infection into long term memory. | Q45755193 | ||
Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry | Q47815571 | ||
Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. | Q52009673 | ||
Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection. | Q52011379 | ||
Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype. | Q52012681 | ||
Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division. | Q52033319 | ||
Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones. | Q52035114 | ||
Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. | Q52040367 | ||
CD28- T lymphocytes. Antigenic and functional properties. | Q52065463 | ||
Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory | Q56904820 | ||
Regulation of CD27 expression on subsets of mature T-lymphocytes | Q72092935 | ||
Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection | Q73020177 | ||
Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs | Q73224609 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Epstein–Barr virus | Q6900 |
P304 | page(s) | 903-911 | |
P577 | publication date | 2003-09-01 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection | |
P478 | volume | 198 |
Q60321325 | A TGF-β mediated regulatory mechanism modulates the T cell immune response to rotavirus in adults but not in children |
Q42202658 | A mutation in X-linked inhibitor of apoptosis (G466X) leads to memory inflation of Epstein-Barr virus-specific T cells |
Q36084979 | A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis. |
Q36228210 | Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation |
Q42229225 | Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults. |
Q37644275 | Analysis of the cross-talk of Epstein-Barr virus-infected B cells with T cells in the marmoset |
Q40254337 | Assessment of CD8(+) T cell differentiation in Trypanosoma cruzi-infected children |
Q37178988 | Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis |
Q35101557 | CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells |
Q36722596 | CD27 expression discriminates porcine T helper cells with functionally distinct properties. |
Q51996932 | CD27- CD4+ memory T cells define a differentiated memory population at both the functional and transcriptional levels. |
Q35216907 | CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors |
Q43761729 | Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein |
Q51889875 | Characteristics of expanded CD4+CD28null T cells in patients with chronic hepatitis B. |
Q51968740 | Characterization of a subset of antigen-specific human central memory CD4+ T lymphocytes producing effector cytokines. |
Q51764698 | Checks and Balances in Autoimmune Vasculitis. |
Q44549769 | Computer-Aided Design of an Epitope-Based Vaccine against Epstein-Barr Virus. |
Q30300254 | Cytomegalovirus infection enhances the immune response to influenza. |
Q21296742 | Cytotoxic CD4 T cells in antiviral immunity |
Q42066029 | Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition |
Q36415765 | Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection |
Q39170011 | Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities |
Q44615180 | Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis |
Q36082304 | Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection |
Q41605285 | Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype |
Q34062231 | Direct ex-vivo evaluation of pneumococcal specific T-cells in healthy adults |
Q34251506 | Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis |
Q35616090 | Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers |
Q42235412 | Donor-derived CD4(+)/CCR7(+) T-cell partial selective depletion does not alter acquired anti-infective immunity. |
Q24657388 | EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2 |
Q34186560 | EBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted function |
Q31108462 | Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis |
Q35798450 | Effects of Sleep Fragmentation and Chronic Latent Viral Infection on Behavior and Inflammation in Mice |
Q35964751 | Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection |
Q34227303 | Epstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ response |
Q35891748 | Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide |
Q36452614 | Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. |
Q36529008 | Functional signatures of protective antiviral T-cell immunity in human virus infections. |
Q36591344 | Generation and maintenance of human memory cells during viral infection. |
Q33280133 | HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts |
Q40351825 | HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity |
Q28302729 | Herpesvirus latency confers symbiotic protection from bacterial infection |
Q35652539 | Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion |
Q40071847 | Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy |
Q39097082 | Human immunity against EBV-lessons from the clinic. |
Q26851748 | Human memory T cells: generation, compartmentalization and homeostasis |
Q44704847 | IL-15 preferentially enhances functional properties and antigen-specific responses of CD4+CD28(null) compared to CD4+CD28+ T cells |
Q92151588 | Immune Control and Vaccination against the Epstein-Barr Virus in Humanized Mice |
Q24795912 | Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection |
Q36410689 | Immune control of Babesia bovis infection |
Q37243692 | Immunophenotypic alterations in acute and early HIV infection |
Q37567836 | Immunotherapy for HIV-associated non-Hodgkin's lymphoma. |
Q55265317 | Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease. |
Q36943860 | Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. |
Q34571341 | Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection |
Q38186778 | Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence? |
Q37500069 | KLRG1--more than a marker for T cell senescence |
Q36835155 | Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection |
Q39441043 | Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation |
Q40351573 | Lymph node and circulating T cell characteristics are strongly correlated in end-stage renal disease patients, but highly differentiated T cells reside within the circulation. |
Q40471906 | MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. |
Q42617680 | MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis. |
Q34152994 | Maintenance of cytomegalovirus-specific CD4pos T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments |
Q41358122 | Molecular mechanisms involved in the aging of the T-cell immune response. |
Q35562281 | NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system. |
Q37888687 | Natural and adoptive T-cell immunity against herpes family viruses after allogeneic hematopoietic stem cell transplantation |
Q45508924 | Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects |
Q36273291 | Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations |
Q33539769 | Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells |
Q37034639 | Perspectives for a protective HIV-1 vaccine |
Q37266382 | Phenotype and function of human T lymphocyte subsets: consensus and issues |
Q36577650 | Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection |
Q91900147 | Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells |
Q37049038 | Primer: making sense of T-cell memory. |
Q36143186 | Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ Production |
Q42723067 | Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity |
Q35853687 | Relationship between functional ability in older people, immune system status, and intensity of response to CMV |
Q36407109 | Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines |
Q40303777 | Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media |
Q44972601 | T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections |
Q36238129 | T cells and viral persistence: lessons from diverse infections |
Q47120971 | T-Cell Composition of the Lymph Node Is Associated with the Risk for Early Rejection after Renal Transplantation. |
Q38597252 | T-Cell Responses to EBV. |
Q39219487 | The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder |
Q34642996 | The T-cell response to HIV. |
Q34400561 | The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation |
Q80576888 | The physiological role of cytotoxic CD4(+) T-cells: the holy grail? |
Q37070576 | Toward a genetics of cancer resistance |
Q35891788 | Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses |
Q34434702 | Virus and cell RNAs expressed during Epstein-Barr virus replication |
Q90715981 | Virus-specific T cells in pediatric renal transplantation |
Q40602726 | When Aging Reaches CD4+ T-Cells: Phenotypic and Functional Changes |
Q36604777 | Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunity |
Search more.